title: High cut-off dialysis as a salvage therapy option in high-dose methotrexate chemotherapy?
authors.affiliation: Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
authors.forename: Anna
authors.initials: A
authors.lastname: Bertram
authors.forename: Philipp
authors.initials: P
authors.lastname: Ivanyi
authors.forename: Carsten
authors.initials: C
authors.lastname: Hafer
authors.forename: Kathrin
authors.initials: K
authors.lastname: Matthias
authors.forename: Dietrich
authors.initials: D
authors.lastname: Peest
authors.forename: Arnold
authors.initials: A
authors.lastname: Ganser
authors.forename: Bernhard M W
authors.initials: BM
authors.lastname: Schmidt
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000628:therapy*; D000368:Aged; D001921:Brain / Q000473:pathology; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D006801:Humans; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced / Q000628:therapy; D002955:Leucovorin / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D008657:Metabolic Clearance Rate; D008727:Methotrexate / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D012008:Recurrence; D006435:Renal Dialysis / Q000379:methods*; D016879:Salvage Therapy
chemical_list: D002955:Leucovorin; D008727:Methotrexate